Trade Summary

1 week ago, Catalyst4, Inc., serving as 10% owner Owner at MapLight Therapeutics, Inc. (MLPT), purchased 1,209,225 shares at $12.66 per share, for a total transaction value of $15,314,793.77. Following this transaction, Catalyst4, Inc. now holds 20,906,689 shares of MLPT.

This purchase represents a 6.14% increase in Catalyst4, Inc.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 6:39 PM ET, 2 days after the trade was made.